CTI
IBB icon

Community Trust & Investment’s iShares Biotechnology ETF IBB Stock Holding History

Community Trust & Investment’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,829
Closed -$250K – 111
2016
Q4 		$250K Buy
+2,829
New +$257K 0.03% 106

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Community Trust & Investment's IBB Position: Q1 2017 in Review

Community Trust & Investment sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 2,829 shares — an estimated $250K sold.

Community Trust & Investment first reported a position in IBB in Q4 2016 and held it in 1 quarter. The position peaked at $250K in Q4 2016. 520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

  • Community Trust & Investment reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
  • Community Trust & Investment sold 2,829 iShares Biotechnology ETF shares in Q1 2017, an estimated $250K.
  • Community Trust & Investment first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 1 quarter.
  • Community Trust & Investment's iShares Biotechnology ETF position peaked at $250K in Q4 2016.
  • 520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Community Trust & Investment's 13F filing for Q1 2017, filed 19 May 2017.